Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

CRUK Oxford Centre Symposium 2020

Oxford’s early detection research is highlighted at this year’s virtual gathering of the Oxford cancer community.

Roadmap for early detection

Cancer Research UK presents the Early Detection and Diagnosis of Cancer Roadmap, with contributions from OxCODE researchers.

Funding boost for OxPLoreD early detection study

UK Research and Innovation provides additional funds for whole genome sequencing as part of the OxPLoreD programme of research into high-risk conditions for blood cancer.

OxCODE researchers at the Early Detection of Cancer Conference 2020

Oxford’s early detection research was featured at this annual event.

Tumour evolution has implications for liquid biopsy

A study of prostate cancer evolution during metastasis observes that liquid biopsies do not capture the complete genetic diversity of the disease within a patient.

OxCODE Associate Director appointed as Professor

Congratulations to Professor Simon Leedham who has been appointed to the Professorship of Molecular and Population Genetics.

Oxfordshire-based SCAN pathway wins BMJ award

A pathway designed to investigate individuals with non-specific but concerning symptoms of cancer wins the BMJ Awards 2020 Cancer Care Team of the Year.

Professor Ellie Barnes comments on the 2020 Nobel Prize for Medicine

Professor Ellie Barnes comments on the recent Nobel Prize in Medicine, awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for their discovery of the Hepatitis C virus, a major global health problem and a cause of cancer.

DPhil in Cancer Science Programme - apply now

The University of Oxford is recruiting its second intake to study for a DPhil in Cancer Science commencing in October 2021.

IGF-1 is a risk factor for several types of cancer

A study of almost 400,000 British participants has identified a new link between raised levels of the growth factor IGF-1 and increased thyroid cancer risk and has confirmed associations with breast, prostate and colorectal cancer.

Early diagnosis projects win NIHR Research Capability Funding

Funding is awarded to expand the number of endoscopy patients taking part in research and to develop new cancer diagnosis and monitoring technologies based on liquid biopsies.

Prioritising patients with unexpected weight loss for cancer investigation

New research will help GPs to identify the signs, symptoms, and blood test results they should look for to swiftly diagnose cancer in people with unexpected weight loss.

Using machine-learning approaches to identify blood cancer types

Improving the accuracy of myeloproliferative neoplasm typing at diagnosis will enable better selection of treatments for improved patient outcomes.

OxCODE funds three early detection projects

Congratulations to Brian Nicholson, Smita Patel, Nicola Sibson and their collaborators who have been awarded funding in the inaugural round of the OxCODE Funding Scheme.

Home tests for colorectal cancer could prioritise patients for referral

Research led by Dr Brian Nicholson enhances non-invasive risk stratification that aims to accelerate the diagnosis of colorectal cancer.

Oxford-based QResearch secures funding for accelerating oesophageal cancer diagnosis

Professor Julia Hippisley-Cox is collaborating on the University of Cambridge-led DELTA programme that aims to diagnose oesophageal cancer earlier.

Oxford University to lead a new national programme of AI research to improve lung cancer screening

UK Research and Innovation, Cancer Research UK and industry are investing more than £11 million in an Oxford-led artificial intelligence (AI) research programme to improve the diagnosis of lung cancer and other thoracic diseases.

Affordable approaches to earlier cancer diagnosis

Dr Toral Gathani wins seed funding as part of Cancer Research UK’s Affordable Approaches to Cancer scheme.

Investigating prostate cancer risk factors using routine blood tests

A UK Biobank study by Dr Eleanor Watts identifies associations between blood count data and risk of prostate cancer incidence and mortality.

Oxford-developed DNA methylation technology forms the basis of new startup company

Biotechnology company, Base Genomics, has launched based on Dr Chunxiao Song’s innovative TAPS technology.

Load More